Docket: 03N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk-Based Approach Comment Number: EC -28
Accepted - Volume 1
Comment Record
Commentor
Mr. Obaid Ali
Date/Time
2003-05-01 15:11:16
Organization
Ministry of Health
Category
Health Professional
Comments for FDA General
Questions
1. General Comments
It is not risk based while providing the confidence over quality of drugs and better health care.